[1]
“IPILIMUMAB IN PATIENTS WITH DISSEMINATED MELANOMA: THE N.N. PETROV NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY EXPANDED ACCESS PROGRAM EXPERIENCE”, Вопр. онкол., vol. 64, no. 3, pp. 388–393, Mar. 2018, doi: 10.37469/0507-3758-2018-64-3-388-393.